Herbert J. Zeh III

  • 17278 Citations
  • 68 h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

1993

Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: Implications for the immunotherapy of cancer

Zeh, H. J., Hurd, S., Storkus, W. J. & Lotze, M. T., Aug 1993, In : Journal of Immunotherapy. 14, 2, p. 155-161 7 p.

Research output: Contribution to journalArticle

89 Scopus citations
1992

Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor

Tweardy, D. J., Morel, P. A., Mott, P. L., Glazer, E. W., Zeh, H. J. & Sakurai, M., 1992, In : Blood. 80, 2, p. 359-366 8 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

New biologic agents come to bat for cancer therapy

Lotze, M. T., Rubin, J. T. & Zeh, H. J., Jan 1 1992, In : Current Opinion in Oncology. 4, 6, p. 1116-1123 8 p.

Research output: Contribution to journalReview article

5 Scopus citations

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma

Lotze, M. T., Zeh, H. J., Elder, E. M., Cai, Q., Pippin, B. A., Rosenstein, M. M., Whiteside, T. L. & Herberman, R., Oct 1992, In : Journal of Immunotherapy. 12, 3, p. 212-217 6 p.

Research output: Contribution to journalArticle

28 Scopus citations